There were significant changes in spleen metabolism in CY, CYLbGp and NC groups at 30 days after treatment, especially the significant difference between CYLbGp and CY groups, indicating that LBP has a regulatory effect on CY induced metabolic disorders. Here, LBP is linked to metabolic disease.